Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients.

Podcast Summary

Introduction: Dr. Warrick Bishop is a practicing cardiologist and passionate health educator who hosts this podcast to help patients understand heart health through education. In this episode, he addresses a common patient question: whether someone with a zero coronary calcium score on CT imaging can safely stop taking cholesterol-lowering medications (statins). This is an important clinical question that lacks a clear-cut answer and requires individualized assessment.

Key Takeaways:

• A zero calcium score is a very good predictor of low cardiovascular risk in average people with average risk factors, but this data doesn't necessarily apply to people with significantly elevated cholesterol levels or other high-risk characteristics.

• High cholesterol levels create an environment where arterial plaque can form, even if plaque hasn't developed yet—much like how living near the sea creates conditions for rust to form on steel.

• Just because someone has no visible plaque now doesn't mean they can safely ignore cholesterol-lowering therapy if they have persistently high cholesterol levels.

• A zero calcium score is reassuring for approximately five years in average patients, but this timeframe is unknown for patients with elevated cholesterol who may need closer monitoring.

• For patients adamant about stopping statins despite high cholesterol, a surveillance strategy should be implemented with repeated imaging every 2-3 years rather than the standard 5-year interval.

• Carotid artery imaging should be checked before discontinuing cholesterol therapy, as it's possible (though rare) to have a zero coronary calcium score while still having plaque in neck arteries.

• The decision to stop cholesterol medications requires detailed consideration of multiple factors including cholesterol levels, age, sex, family history, lipoprotein(a), weight, exercise habits, and overall risk profile.

• Current guidelines generally support continuing cholesterol-lowering therapy in patients with elevated cholesterol levels, regardless of calcium score results.

• Lifestyle modifications (avoiding cigarettes, controlling blood pressure, maintaining healthy weight, regular exercise, and good diet) are essential factors in any decision to discontinue medication.

• There is no one-size-fits-all answer to this question; it requires individualized discussion and a tailored monitoring plan between patient and physician.